4.5 Article

Hepatitis C virus and carpal tunnel syndrome in hemodialysis patients: a single center cross-sectional study

Journal

RENAL FAILURE
Volume 42, Issue 1, Pages 1076-1082

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/0886022X.2020.1832522

Keywords

Carpal tunnel syndrome; beta 2-microglobulin; hepatitis C virus; hemodialysis; related factors

Ask authors/readers for more resources

Objectives: Carpal tunnel syndrome (CTS) is a common complication in maintenance hemodialysis (MHD) patients and leads to disabilities and increased risk of mortality. Hepatitis C virus (HCV) infection is associated with inflammatory and oxidative stress, and HCV infection can be cured. This study aimed at evaluating the association of HCV infection with CTS. Methods: Using a cross-sectional design, anthropometric and laboratory data were collected. Serum beta(2)-microglobulin, HCV antibody and HCV-RNA were measured. CTS was diagnosed according to clinical manifestation, electrophysiological test or ultrasonography. The related factors for CTS were analyzed by multivariate logistic regression. Results: This study included 113 participants, of whom 33 (29.2%) patients were positive for HCV antibody and 18 (15.9%) were positive for HCV antibody and HCV-RNA. Thirty-two (28.3%) patients were diagnosed with CTS. There were significant differences in the dialysis vintage, age of onset of MHD, high-sensitivity C-reactive protein, serum beta M-2, anti-HCV-positive, HCV-RNA-positive, HCV load values and urine volume category between the CTS group and non-CTS group (p < 0.05). High-sensitivity C-reactive protein (OR: 1.238, 95% CI: 1.071-1.431,p = 0.004), dialysis vintage (OR: 1.017, 95% CI: 1.008-1.026,p < 0.001) and HCV-RNA-positive (OR: 5.929, 95% CI: 1.295-27.132,p = 0.022) rather than anti-HCV-positive were related factors for CTS. Conclusions: High-sensitivity C-reactive protein, dialysis vintage and HCV-RNA replication but not previous HCV-infection were related factors for CTS in MHD patients. Further studies are needed to clarify whether intervention is beneficial for preventing and delaying the progression of CTS in MHD patients with HCV-RNA replication.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available